Gastrointestinal complications of immunosuppression

Gastroenterology Clinics of North America

Volumn 28, Issue 1, 1999, Pages 233-245

  Nunes, F A ^a   Lucey, M R ^a  

^a 3 Ravdin   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; MONOCLONAL ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; TACROLIMUS; THYMOCYTE ANTIBODY;

ABDOMINAL PAIN; DIARRHEA; DYSPHAGIA; GASTROINTESTINAL SYMPTOM; GRAFT VERSUS HOST REACTION; HUMAN; INFECTIOUS COMPLICATION; LIVER TOXICITY; NAUSEA; PANCREATITIS; PEPTIC ULCER; REVIEW; VOMITING;

EID: 0032913310     PISSN: 08898553     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8553(05)70052-2     Document Type: Article

References (35)

1. J. Burdick G. Vogelsang W. Smith Severe graft versus host disease in a liver transplant recipient N Engl J Med 318 1988 689
2. L. Collins M. Samore M. Roberts Risk factors for fungal infections complicating orthotopic liver transplantation J Infect Dis 170 1994 644
3. J. Dienstag R. Perillo E. Schiff A preliminary trial of lamuvidine for chronichepatitis B infection N Engl J Med 333 1995 1657
4. D. George P. Arnow A. Fox Bacterial infection as a complication of liver transplantation: Epidemiology and risk factors Rev Infect Dis 13 1991 387
5. O.M.S. Group A randomized clinical trial of OKT3 monoclonal antibody for acute rejection of cadaveric renal transplants N Engl J Med 313 1995 337
6. S. Kanj A. Sharara P. Clavien CMV infection after liver transplantation: A review Clin Infect Dis 22 1996 537
7. P. Ljungman V. Duraj L. Magnius Hepatitis C infection in allogeneic bone marrow transplant recipients Clin Transplant 5 1991 283
8. S.V. McDiarmid Mycophenolate mofetil in liver transplantation Clin Transplant 10 1996 140
9. G. McDonald H. Shulman K. Sullivan Intestinal and hepatic complications of human bone marrow transplantation: Part I Gastroenterology 90 1986 460
10. G. McDonald H. Shulman K. Sullivan Intestinal and hepatic complications of human bone marrow transplantation: Part II Gastroenterology 90 1986 460
11. R. Parkman Graft-versus-host disease Annu Rev Med 42 1991 129
12. R. Parkman Human graft-versus-host disease Immunodeficiency Rev 2 1991 253
13. K. Portela R. Patel J. Larson-Keller OKT3 treatment for allograft rejection is a risk factor for cytomegalovirus disease in liver transplantation J Infect Dis 171 1995 1014
14. E. Reed D. Myerson L. Corey Allogeneic marrow transplantation in patients positive of hepatitis B surface antigen Blood 77 1991 195
15. J. Roberts N. Ascher J. Lake Graft versus host disease after liver transplantation in humans: A report of 4 cases Hepatology 14 1991 274
16. R.H. Rubin Preemptive therapy in immunocompromised hosts [editorial; comment] N Engl J Med 324 1991 1057
17. R.H. Rubin Prevention of infection in the liver transplant recipient Liver Transplant Surg 2 1996 89
18. R.H. Rubin N.E. Tolkoff-Rubin Opportunistic infections in renal allograft recipients Transplant Proc 20 1988 12
19. R.H. Rubin J.S. Wolfson A.B. Cosimi Infection in the renal transplant recipient Am J Med 70 1981 405
20. V. Rustgi Epstein-Barr viral infection and post transplantation lymphoproliferative disorders Liver Transplant Surg 1 1995 100
21. S. Schreiber G. Crabtree The mechanism of action of cyclosporin A and FK506 Immunol Today 13 1992 136
22. T. Schroeder M. First Monoclonal antibodies in organ transplantation Am J Kidney Dis 23 1994 138
23. P. Smith S. Saini J. Orenstein Infections of the large intestine in the immunocompromised host Phillips S. Pemberton J. Shorter R. The Large Intestine: Physiology, Pathophysiology, and Disease 1991 Raven New York 437
24. M. Sterneck R. Weisner N. Ascher Azathioprine hepatotoxicity after liver transplantation Hepatology 14 1991 806
25. C. Surawicz D. Grahm Viral colitis Phillips S. Pemberton J. Shorter R. The Large Intestine: Physiology, Pathophysiology, and Disease 1991 Raven New York 429
26. L. Swinnen M. Costanzo-Nordin S. Fisher Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac transplant recipients N Engl J Med 323 1990 1723
27. R. Tur-Kaspa O. Laub Corticosteroids stimulate hepatitis B virus DNA, mRNA and protein production in a stable expression system J Hepatol 11 1990 34
28. J. Vonderscher A. Meinzer Rationale for the development of sandimmune neoral Transplant Proc 26 1994 2925
29. J. Wade N. Rolando K. Hayllar Bacterial and fungal infections after liver transplantation: An analysis of 284 patients Hepatology 21 1995 1328
30. R. Walker C. Paya W. Marshall Pretransplantation seronegative Epstein-Barr virus status is the primary risk factor for post transplantation lymphoproliferative disorder in adult heart, lung, and other solid organ transplantations J Heart Lung Transplant 14 1995 214
31. C. Walsh L. Zydowsky F. McKeon Cyclosporin A, the cyclophilin class of peptidylprolyl isomerases, and blockade of T cell signal transduction J Biol Chem 267 1992 1315
32. A. Webster M. Brenner H. Prentice Fatal hepatitis B B reactivation after autologous BMT Bone Marrow Transplant 4 1989 207
33. D.J. Weisdorf D.C. Snover R. Haake Acute upper gastrointestinal graft-versus-host disease: Clinical significance and response to immunosuppressive therapy Blood 76 1990 624
34. D. Winston C. Emmanouilides R. Busuttil Infections in liver transplant recipients Clin Infect Dis 21 1995 1077
35. D. Winston D. Imagawa C. Holt Long term ganciclovir prophylaxis eliminates serious cytomegalovirus disease in liver transplant recipients recieving OKT3 therapy for rejection Transplantation 60 1995 1357